Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Akoya Biosciences Inc
(NQ:
AKYA
)
3.810
-0.090 (-2.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Akoya Biosciences Inc
< Previous
1
2
3
4
Next >
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
April 22, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
April 05, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023
March 04, 2024
AKYA stock results show that Akoya Biosciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: Akoya Biosciences Q4 Earnings
March 04, 2024
Via
Benzinga
Earnings Outlook For Akoya Biosciences
March 01, 2024
Via
Benzinga
Analyst Ratings for Akoya Biosciences
December 14, 2023
Via
Benzinga
Expert Ratings for Akoya Biosciences
November 13, 2023
Via
Benzinga
Recap: Akoya Biosciences Q3 Earnings
November 08, 2023
Via
Benzinga
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
March 04, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 4, 2024
March 04, 2024
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.
Via
Benzinga
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
February 08, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Where Akoya Biosciences Stands With Analysts
October 16, 2023
Via
Benzinga
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
January 18, 2024
PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
January 10, 2024
Leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational, clinical, and diagnostic applications of Akoya’s spatial biology solutions
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow
January 07, 2024
The Thermo Fisher Scientific ViewRNA technology combined with Akoya’s market leading spatial biology solutions will enable rapid, whole-slide imaging of RNA and protein biomarkers
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
January 07, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
January 07, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
November 08, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at Three Upcoming Investor Conferences
November 02, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023
October 31, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures
October 17, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023
October 11, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms
September 19, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
August 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
August 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at Three Upcoming Investor Conferences
July 26, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner'
July 20, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tripadvisor, Inc. (NASDAQ: TRIP) is not good enough, and he prefers Booking Holdings Inc. (NASDAQ: BKNG).
Via
Benzinga
Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023
July 12, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Virgin Galactic, Squarespace And Other Big Stocks Moving Higher In Friday's Pre-Market Session
June 16, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.